Terra Slaton

653 total citations
26 papers, 507 citations indexed

About

Terra Slaton is a scholar working on Surgery, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Terra Slaton has authored 26 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Terra Slaton's work include Inflammatory Bowel Disease (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Pharmaceutical studies and practices (3 papers). Terra Slaton is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Pharmaceutical studies and practices (3 papers). Terra Slaton collaborates with scholars based in United States, Canada and Switzerland. Terra Slaton's co-authors include Chris M Kozma, Pat Ray Reese, Brigitte Schurch, P. Denys, Rich Barron, Richard Barron, Brigitta U. Monz, Richard V. Hodder, George J. Wan and Brian G. Feagan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Terra Slaton

25 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Terra Slaton United States 13 146 143 104 100 91 26 507
Steven Weissbart United States 13 207 1.4× 175 1.2× 69 0.7× 101 1.0× 14 0.2× 54 580
A Bakke Norway 14 251 1.7× 279 2.0× 36 0.3× 100 1.0× 37 0.4× 29 826
Daniele Bianchi Italy 9 85 0.6× 87 0.6× 46 0.4× 79 0.8× 56 0.6× 39 419
Kerstin Allen United States 9 151 1.0× 66 0.5× 228 2.2× 225 2.3× 15 0.2× 22 833
Jessica C. Lloyd United States 13 306 2.1× 201 1.4× 71 0.7× 170 1.7× 43 0.5× 27 550
Emily Durden United States 12 57 0.4× 111 0.8× 17 0.2× 52 0.5× 24 0.3× 25 455
Chi‐Hang Yee Hong Kong 13 221 1.5× 92 0.6× 236 2.3× 148 1.5× 7 0.1× 60 561
Mandy Wells United Kingdom 9 194 1.3× 273 1.9× 12 0.1× 92 0.9× 18 0.2× 21 454
Maite Pérez Spain 12 111 0.8× 166 1.2× 138 1.3× 76 0.8× 83 0.9× 43 486
Graham Hollins United Kingdom 12 54 0.4× 37 0.3× 149 1.4× 104 1.0× 46 0.5× 18 476

Countries citing papers authored by Terra Slaton

Since Specialization
Citations

This map shows the geographic impact of Terra Slaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terra Slaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terra Slaton more than expected).

Fields of papers citing papers by Terra Slaton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terra Slaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terra Slaton. The network helps show where Terra Slaton may publish in the future.

Co-authorship network of co-authors of Terra Slaton

This figure shows the co-authorship network connecting the top 25 collaborators of Terra Slaton. A scholar is included among the top collaborators of Terra Slaton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terra Slaton. Terra Slaton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fitzgerald, Timothy, Amanda Teeple, Terra Slaton, & Chris M Kozma. (2021). Characteristics of Patients Initiating Guselkumab for Plaque Psoriasis in the Symphony Health Claims Database.. Journal of Drugs in Dermatology. 20(10). 1127–1131. 1 indexed citations
3.
4.
Ding, Zhijie, et al.. (2019). Mo1908 – Nonbiologic Drug Use Before and After Initiation of Ustekinumab Or Adalimumab for Crohn’s Disease Patients. Gastroenterology. 156(6). S–882. 1 indexed citations
5.
Muser, Erik, et al.. (2018). P313 Steroid and opioid use among Crohn’s patients before and after initiation of ustekinumab. Journal of Crohn s and Colitis. 12(supplement_1). S259–S259. 1 indexed citations
6.
Roberts, Melissa, Emmanuelle Clerisme-Beaty, Chris M Kozma, et al.. (2016). A retrospective analysis to identify predictors of COPD-related rehospitalization. BMC Pulmonary Medicine. 16(1). 68–68. 31 indexed citations
7.
Kozma, Chris M, Terra Slaton, R. Scott McKenzie, Brad Schenkel, & Lorie Ellis. (2015). Mantle Cell Lymphoma (MCL) Treatment Patterns, Healthcare Resource Use (HRU), and Costs in the United States. Clinical Lymphoma Myeloma & Leukemia. 15. S226–S226. 1 indexed citations
8.
Wan, George J., Chris M Kozma, Terra Slaton, William H. Olson, & Brian G. Feagan. (2014). Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy. Journal of Medical Economics. 17(6). 384–393. 24 indexed citations
9.
Feagan, Brian G., Chris M Kozma, Terra Slaton, William H. Olson, & George J. Wan. (2014). Healthcare costs for Crohn’s disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence. Journal of Medical Economics. 17(12). 872–880. 14 indexed citations
10.
Kozma, Chris M, David Provenzano, Terra Slaton, Aarti A. Patel, & Carmela Benson. (2014). Complexity of Pain Management Among Patients with Nociceptive or Neuropathic Neck, Back, or Osteoarthritis Diagnoses. Journal of Managed Care Pharmacy. 20(5). 455–466. 17 indexed citations
11.
Lafeuille, Marie‐Hélène, Patrick Lefèbvre, Lorie Ellis, et al.. (2014). Adherence Patterns for Abiraterone Acetate and Concomitant Prednisone Use in Patients with Prostate Cancer. Journal of Managed Care Pharmacy. 20(5). 477–484. 30 indexed citations
12.
Kozma, Chris M, Terra Slaton, Lorie Ellis, & R. Scott McKenzie. (2014). Abstract 4139: Healthcare resource utilization (HRU) in treated mantle cell lymphoma (MCL) patients. Cancer Research. 74(19_Supplement). 4139–4139. 3 indexed citations
13.
Kozma, Chris M, et al.. (2013). Cost and utilization of healthcare services for hip and knee replacement. Journal of Medical Economics. 16(7). 888–896. 31 indexed citations
14.
Kozma, Chris M, et al.. (2011). Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study. BMC Pulmonary Medicine. 11(1). 61–61. 12 indexed citations
15.
Lerner, Jason, et al.. (2011). Comparative Hospital Economics and Patient Presentation: Vertebroplasty and Kyphoplasty for the Treatment of Vertebral Compression Fracture. American Journal of Neuroradiology. 32(7). 1290–1294. 24 indexed citations
16.
Schurch, Brigitte, P. Denys, Chris M Kozma, et al.. (2007). Botulinum Toxin A Improves the Quality of Life of Patients with Neurogenic Urinary Incontinence. European Urology. 52(3). 850–859. 74 indexed citations
17.
Freitag, Fred, Chris M Kozma, Terra Slaton, Jane T. Osterhaus, & Rich Barron. (2005). Characterization and Prediction of Emergency Department Use in Chronic Daily Headache Patients. Headache The Journal of Head and Face Pain. 45(7). 891–898. 22 indexed citations
18.
Kozma, Chris M, Terra Slaton, Brigitta U. Monz, Richard V. Hodder, & Pat Ray Reese. (2005). Development and Validation of a Patient Satisfaction and Preference Questionnaire for Inhalation Devices. PubMed. 4(1). 41–52. 55 indexed citations
19.
Kozma, Chris M, Victoria Barghout, Terra Slaton, Feride Frech, & C. Eugene Reeder. (2002). A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma.. PubMed. 15(9). 40–3, 49. 12 indexed citations
20.
Slaton, Terra, Walter W. Piegorsch, & S. D. Durham. (2000). Estimation and Testing with Overdispersed Proportions Using the Beta‐Logistic Regression Model of Heckman and Willis. Biometrics. 56(1). 125–133. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Weissbart Breakdown of academic impact, for papers by A Bakke Breakdown of academic impact, for papers by Daniele Bianchi Breakdown of academic impact, for papers by Kerstin Allen Breakdown of academic impact, for papers by Jessica C. Lloyd Breakdown of academic impact, for papers by Emily Durden Breakdown of academic impact, for papers by Chi‐Hang Yee Breakdown of academic impact, for papers by Mandy Wells Breakdown of academic impact, for papers by Maite Pérez Breakdown of academic impact, for papers by Graham Hollins
Rankless by CCL
2026